Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Genetic polymorphism in Gilbert-Meulengracht syndrome (GMS)].

Zeitschrift fur Gastroenterologie - 1 Feb 1993

Fengler J D, Baumgarten R, Eike E, Eike O, Siegmund W, Franke G, Zschiesche M

Abstract excerpt

N-Acetylation and debrisoquine hydroxylation phenotypes were determined in 54 patients with Gilbert's syndrome and in 247 (sulfamethazine) and 76 (debrisoquine) non-related healthy volunteers, respectively. 40 (74.1%) of the patients and 135 (54.7%) of healthy volunteers were slow acetylators (chi 2 = 6.87). In patients, the cumulative urinary excretion (CUE) of sulfamethazine (0-6 hours) was significantly...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acetylation
Share to Arylamine N-Acetyltransferase
Share to Cytochrome P-450 CYP2D6

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cytochrome P-450 Enzyme System

Share to Debrisoquin

Share to Mixed Function Oxygenases

Share to Phenotype

Share to Polymorphism, Genetic

Source

Identifiers

PMID: 7483725

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Genetic polymorphism in Gilbert-Meulengracht syndrome (GMS)].PMID 7483725Read ↗

N-acetylation and debrisoquine hydroxylation polymorphisms in patients with Gilbert's syndrome.Semantic proximity Read ↗

Debrisoquine hydroxylation and sulfamethazine acetylation in a Chinese population.Semantic proximity Read ↗

Pharmacogenetics of Debrisoquine and its Use as a Marker For CYP2D6 Hydroxylation CapacitySemantic proximity Read ↗

Debrisoquine 4-hydroxylation and sulphamethazine N-acetylation in patients with schizophrenia and major depression.Semantic proximity Read ↗

Plasma levels of thioridazine and metabolites are influenced by the debrisoquin hydroxylation phenotype.Semantic proximity Read ↗

Prediction of phenotype for acetylation and for debrisoquine hydroxylation by DNA-tests in healthy human volunteers.Semantic proximity Read ↗

Genetically determined adverse drug reactions involving metabolism.Semantic proximity Read ↗

[Knowledge about metabolic capacity is important in drug therapy].Semantic proximity Read ↗

Debrisoquine oxidation in an Italian population: a study in healthy subjects and in schizophrenic patients.Semantic proximity Read ↗

Haloperidol disposition is dependent on debrisoquine hydroxylation phenotype.Semantic proximity Read ↗

Pronounced differences between native Chinese and Swedish populations in the polymorphic hydroxylations of debrisoquin and S-mephenytoin.Semantic proximity Read ↗

[Assessment of biotransformation capacity following oral administration of various model substances as cocktail].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.